Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
TKNO

TKNO - Alpha Teknova, Inc. Stock Price, Fair Value and News

$2.98-0.18 (-5.70%)
Market Closed

33/100

TKNO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

33/100

TKNO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.7

Target 3M

$3.15

Target 6M

$2.99

TKNO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TKNO Price Action

Last 7 days

-9.4%

Last 30 days

-23%

Last 90 days

-41.1%

Trailing 12 Months

-68.8%

TKNO RSI Chart

TKNO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TKNO Valuation

Market Cap

159.5M

Price/Earnings (Trailing)

-8.76

Price/Sales (Trailing)

4.01

EV/EBITDA

-13.7

Price/Free Cashflow

-15.21

TKNO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.7

Target 3M

$3.15

Target 6M

$2.99

TKNO Fundamentals

TKNO Revenue

Revenue (TTM)

39.8M

Rev. Growth (Yr)

9.17%

Rev. Growth (Qtr)

1.62%

TKNO Earnings

Earnings (TTM)

-18.2M

Earnings Growth (Yr)

43.34%

Earnings Growth (Qtr)

-20.06%

TKNO Profitability

EBT Margin

-45.57%

Return on Equity

-25.08%

Return on Assets

-16.93%

Free Cashflow Yield

-6.57%

TKNO Investor Care

Shares Dilution (1Y)

0.42%

Diluted EPS (TTM)

-0.33

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202538.3M38.9M39.8M0
202436.9M34.9M36.3M37.7M
202339.4M39.2M36.7M36.7M
202239.0M42.3M43.6M41.4M
202132.7M34.1M35.5M36.9M
202000031.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About Alpha Teknova, Inc.

TKNO
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
 CEO
 WEBSITEteknova.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES285

Alpha Teknova, Inc. Frequently Asked Questions

TKNO is the stock ticker symbol of Alpha Teknova, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Alpha Teknova, Inc. is 159.52 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check TKNO's fair value in chart for subscribers.

The fair value guage provides a quick view whether TKNO is over valued or under valued. Whether Alpha Teknova, Inc. is cheap or expensive depends on the assumptions which impact Alpha Teknova, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TKNO.

As of Wed Jan 28 2026, TKNO's PE ratio (Price to Earnings) is -8.76 and Price to Sales (PS) ratio is 4.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TKNO PE ratio will change depending on the future growth rate expectations of investors.